American Healthcare REIT (AHR) Financials

$32.48 +0.07 (+0.22%)

Closing price 03:59 PM Eastern

Extended Trading

$32.61 +0.13 (+0.40%)

As of 07:47 PM Eastern

Annual Income Statements for American Healthcare REIT

This table shows American Healthcare REIT's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-48	-81	-71	-38
Consolidated Net Income / (Loss)	-53	-73	-77	-36
Net Income / (Loss) Continuing Operations	-53	-73	-77	-36
Total Pre-Tax Income	-52	-73	-76	-34
Total Operating Income	21	28	47	84
Total Gross Profit	252	362	364	417
Total Revenue	1,282	1,643	1,867	2,071
Operating Revenue	1,282	1,643	1,867	2,071
Total Cost of Revenue	1,030	1,282	1,502	1,654
Operating Cost of Revenue	1,030	1,282	1,502	1,654
Total Operating Expenses	231	334	317	333
Selling, General & Admin Expense	43	43	48	48
Depreciation Expense	133	168	183	179
Other Operating Expenses / (Income)	39	60	57	53
Impairment Charge	3.34	78	24	46
Restructuring Charge	13	4.39	5.80	7.14
Other Special Charges / (Income)	0.00	-20	-0.73	0.00
Total Other Income / (Expense), net	-73	-101	-123	-118
Interest Expense	81	106	163	128
Interest & Investment Income	0.50	4.47	5.88	4.49
Other Income / (Expense), net	7.54	0.78	34	5.47
Income Tax Expense	0.96	0.59	0.66	1.71
Net Income / (Loss) Attributable to Noncontrolling Interest	-5.48	7.92	-5.42	2.21
Basic Earnings per Share	($0.95)	($1.24)	($1.08)	($0.29)
Weighted Average Basic Shares Outstanding	50.08M	65.81M	66.05M	130.64M
Diluted Earnings per Share	($0.95)	($1.24)	($1.08)	($0.29)
Weighted Average Diluted Shares Outstanding	50.08M	65.81M	66.05M	130.64M
Weighted Average Basic & Diluted Shares Outstanding	-	-	65.37M	157.57M
Cash Dividends to Common per Share	$0.69	$1.60	$1.00	$1.00

This table shows American Healthcare REIT's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-14	-	-26	-12	-5.99	-27	-3.89	1.98	-4.13	-32
Consolidated Net Income / (Loss)	-7.64	-	-28	-12	-6.45	-31	-3.00	2.93	-3.09	-32
Net Income / (Loss) Continuing Operations	-7.64	-	-28	-12	-6.45	-31	-3.00	2.93	-3.09	-32
Total Pre-Tax Income	-7.52	-	-27	-12	-6.16	-31	-2.73	3.61	-2.83	-32
Total Operating Income	21	-	9.56	23	0.91	14	25	32	34	-6.41
Total Gross Profit	89	-	82	95	90	98	96	102	107	112
Total Revenue	426	-	452	468	464	483	500	505	524	543
Operating Revenue	426	-	452	468	464	483	500	505	524	543
Total Cost of Revenue	337	-	370	373	375	385	404	403	417	431
Operating Cost of Revenue	337	-	370	373	375	385	404	403	417	431
Total Operating Expenses	67	-	73	72	89	84	71	70	73	119
Selling, General & Admin Expense	9.63	-	13	12	11	11	12	12	12	12
Depreciation Expense	40	-	45	45	49	44	43	45	44	47
Other Operating Expenses / (Income)	15	-	15	15	15	13	14	13	13	13
Restructuring Charge	0.23	-	0.33	0.89	1.02	3.55	2.78	0.02	3.54	0.81
Total Other Income / (Expense), net	-29	-	-37	-35	-7.08	-45	-28	-28	-37	-26
Interest Expense	28	-	39	41	42	41	36	31	30	30
Interest & Investment Income	0.33	-	1.30	2.48	1.25	0.86	0.66	2.07	0.02	1.74
Other Income / (Expense), net	-1.58	-	0.68	3.99	34	-4.50	8.25	0.47	-6.28	3.03
Income Tax Expense	0.13	-	0.14	0.35	0.28	-0.11	0.28	0.69	0.26	0.49
Net Income / (Loss) Attributable to Noncontrolling Interest	5.86	-	-1.74	0.32	-0.46	-3.53	0.89	0.95	1.03	-0.66
Basic Earnings per Share	($0.21)	-	($0.39)	($0.19)	($0.09)	($0.41)	($0.04)	$0.01	($0.03)	($0.23)
Weighted Average Basic Shares Outstanding	65.82M	65.81M	66.03M	66.03M	66.05M	66.05M	104.30M	130.53M	133.73M	130.64M
Diluted Earnings per Share	($0.21)	-	($0.39)	($0.19)	($0.09)	($0.41)	($0.04)	$0.01	($0.03)	($0.23)
Weighted Average Diluted Shares Outstanding	65.82M	65.81M	66.03M	66.03M	66.05M	66.05M	104.30M	130.69M	133.73M	130.64M
Weighted Average Basic & Diluted Shares Outstanding	-	0.00	-	-	66.23M	65.37M	131.65M	131.65M	153.06M	157.57M

This table details how cash moves in and out of American Healthcare REIT's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-27	-14	-21	33
Net Cash From Operating Activities	18	148	99	176
Net Cash From Continuing Operating Activities	18	148	99	176
Net Income / (Loss) Continuing Operations	-53	-73	-77	-36
Consolidated Net Income / (Loss)	-53	-73	-77	-36
Depreciation Expense	133	168	183	179
Amortization Expense	24	33	55	42
Non-Cash Adjustments To Reconcile Net Income	-1.32	59	-7.01	60
Changes in Operating Assets and Liabilities, net	-85	-38	-55	-70
Net Cash From Investing Activities	-139	-119	9.40	-8.73
Net Cash From Continuing Investing Activities	-139	-119	9.40	-8.73
Purchase of Property, Plant & Equipment	-80	-145	-145	-152
Acquisitions	-1.20	-19	-13	-0.24
Sale of Property, Plant & Equipment	4.50	48	185	141
Sale and/or Maturity of Investments	-	0.00	6.08	30
Other Investing Activities, net	0.00	-3.55	-23	-28
Net Cash From Financing Activities	94	-43	-129	-135
Net Cash From Continuing Financing Activities	94	-43	-129	-135
Repayment of Debt	-196	-1,241	-566	-1,953
Repurchase of Preferred Equity	-8.93	-	-	-36
Repurchase of Common Equity	-0.39	-23	-1.96	-73
Payment of Dividends	-39	-67	-86	-125
Issuance of Debt	350	1,280	562	954
Issuance of Common Equity	-	0.00	0.00	1,364
Other Financing Activities, net	-11	7.04	-36	-267
Cash Interest Paid	70	89	153	116
Cash Income Taxes Paid	1.24	1.13	1.30	1.32

This table details how cash moves in and out of American Healthcare REIT's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-	-13	-24	5.51	-11	8.58	34	-27	19	6.73
Net Cash From Operating Activities	-	34	24	20	29	26	-5.95	59	63	60
Net Cash From Continuing Operating Activities	-	34	24	20	29	26	-5.95	59	63	60
Net Income / (Loss) Continuing Operations	-	-49	-28	-12	-6.45	-31	-3.00	2.93	-3.09	-32
Consolidated Net Income / (Loss)	-	-49	-28	-12	-6.45	-31	-3.00	2.93	-3.09	-32
Depreciation Expense	-	45	45	45	49	44	43	45	44	47
Amortization Expense	-	11	20	12	14	8.12	12	11	9.65	10
Non-Cash Adjustments To Reconcile Net Income	-	33	-1.37	1.71	-16	8.73	1.46	3.46	1.54	53
Changes in Operating Assets and Liabilities, net	-	-5.93	-12	-27	-12	-4.07	-59	-3.09	11	-18
Net Cash From Investing Activities	-	3.96	-33	43	11	-11	-5.22	-60	-30	87
Net Cash From Continuing Investing Activities	-	3.96	-33	43	11	-11	-5.22	-60	-30	87
Purchase of Property, Plant & Equipment	-	-18	-33	-31	-55	-25	-20	-65	-30	-38
Acquisitions	-	-0.42	-6.34	-6.00	-	-0.59	0.00	-	-	-0.24
Sale of Property, Plant & Equipment	-	23	6.90	81	80	17	15	-0.00	0.01	127
Sale and/or Maturity of Investments	-	-	0.00	-	-	6.08	8.38	11	4.40	6.45
Other Investing Activities, net	-	-0.03	-0.71	-0.31	-14	-8.06	-7.89	-6.64	-5.26	-7.82
Net Cash From Financing Activities	-	-51	-14	-57	-52	-5.89	45	-26	-14	-140
Net Cash From Continuing Financing Activities	-	-51	-14	-57	-52	-5.89	45	-26	-14	-140
Repayment of Debt	-	-168	-88	-168	-150	-160	-799	-277	-339	-538
Repurchase of Common Equity	-	-5.88	-0.08	-0.87	-16	15	-48	-1.94	-57	33
Payment of Dividends	-	-20	-31	-20	-18	-18	-18	-34	-34	-39
Issuance of Debt	-	122	121	139	143	158	163	299	168	325
Issuance of Common Equity	-	-	0.00	-	-	-	773	-	471	120
Other Financing Activities, net	-	20	-0.88	-7.03	-27	-1.54	-0.73	-37	-223	-5.14
Cash Interest Paid	-	28	37	39	38	39	36	27	28	25
Cash Income Taxes Paid	-	0.48	0.38	0.41	0.22	0.28	0.16	0.58	0.16	0.43

This table presents American Healthcare REIT's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	4,787	4,578	4,488
Total Current Assets	203	229	288
Cash & Equivalents	65	43	77
Accounts Receivable	138	185	211
Plant, Property, & Equipment, net	3,582	3,425	3,367
Total Noncurrent Assets	1,003	924	834
Goodwill	232	235	235
Intangible Assets	236	180	161
Other Noncurrent Operating Assets	535	508	437
Total Liabilities & Shareholders' Equity	4,787	4,578	4,488
Total Liabilities	3,137	3,119	2,184
Total Current Liabilities	244	243	258
Accounts Payable	244	243	258
Total Noncurrent Liabilities	2,894	2,876	1,926
Long-Term Debt	2,512	2,526	1,671
Capital Lease Obligations	273	226	165
Noncurrent Deferred Revenue	50	76	52
Other Noncurrent Operating Liabilities	59	48	38
Commitments & Contingencies	0.00	0.00	0.00
Redeemable Noncontrolling Interest	82	34	0.22
Total Equity & Noncontrolling Interests	1,568	1,425	2,304
Total Preferred & Common Equity	1,400	1,270	2,261
Preferred Stock	0.00	0.00	0.00
Total Common Equity	1,400	1,270	2,261
Common Stock	2,541	2,549	3,722
Retained Earnings	-1,138	-1,276	-1,458
Accumulated Other Comprehensive Income / (Loss)	-2.69	-2.43	-2.51
Noncontrolling Interest	168	155	43

This table presents American Healthcare REIT's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	4,589	4,703	4,645	4,677
Total Current Assets	205	293	253	272
Cash & Equivalents	35	77	52	68
Accounts Receivable	169	216	201	204
Plant, Property, & Equipment, net	0.00	3,479	3,510	3,536
Total Noncurrent Assets	4,384	932	882	870
Goodwill	235	235	235	235
Intangible Assets	197	188	179	178
Other Noncurrent Operating Assets	3,952	509	468	457
Total Liabilities & Shareholders' Equity	4,589	4,703	4,645	4,677
Total Liabilities	3,055	2,561	2,541	2,420
Total Current Liabilities	234	257	254	270
Accounts Payable	234	257	254	270
Total Noncurrent Liabilities	2,821	2,303	2,287	2,150
Long-Term Debt	2,498	1,988	2,012	1,879
Capital Lease Obligations	-	220	179	174
Noncurrent Deferred Revenue	44	49	50	52
Other Noncurrent Operating Liabilities	279	47	46	45
Commitments & Contingencies	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	60	12	0.22	0.22
Total Equity & Noncontrolling Interests	1,474	2,131	2,104	2,257
Total Preferred & Common Equity	1,314	1,961	1,933	2,207
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	1,314	1,961	1,933	2,207
Common Stock	2,549	3,277	3,280	3,596
Retained Earnings	-1,232	-1,313	-1,344	-1,387
Accumulated Other Comprehensive Income / (Loss)	-2.62	-2.47	-2.46	-2.15
Noncontrolling Interest	159	170	171	49

This table displays calculated financial ratios and metrics derived from American Healthcare REIT's official financial filings.

Metric	2021	2022	2023	2024
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	28.15%	13.60%	10.93%
EBITDA Growth	0.00%	23.60%	38.86%	-2.32%
EBIT Growth	0.00%	2.00%	182.64%	10.20%
NOPAT Growth	0.00%	35.57%	69.21%	77.61%
Net Income Growth	0.00%	-37.76%	-4.77%	53.70%
EPS Growth	0.00%	-30.53%	12.90%	73.15%
Operating Cash Flow Growth	0.00%	724.92%	-33.32%	78.71%
Free Cash Flow Firm Growth	0.00%	0.00%	105.39%	-30.48%
Invested Capital Growth	0.00%	0.00%	-4.61%	-2.50%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	2.99%
EBITDA Q/Q Growth	0.00%	0.00%	31.68%	-2.40%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-12.39%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-19.38%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-4.31%
EPS Q/Q Growth	0.00%	0.00%	0.00%	38.30%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-7.99%	23.70%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	194.38%
Invested Capital Q/Q Growth	0.00%	0.00%	4.27%	-4.22%
Profitability Metrics	-	-	-	-
Gross Margin	19.66%	22.01%	19.52%	20.13%
EBITDA Margin	14.47%	13.95%	17.06%	15.02%
Operating Margin	1.61%	1.70%	2.53%	4.05%
EBIT Margin	2.19%	1.75%	4.34%	4.32%
Profit (Net Income) Margin	-4.15%	-4.47%	-4.12%	-1.72%
Tax Burden Percent	101.83%	100.81%	100.87%	105.06%
Interest Burden Percent	-186.00%	-253.75%	-94.01%	-37.92%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.89%	0.77%	1.43%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-5.94%	-3.28%	-2.80%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-9.79%	-5.72%	-3.32%
Return on Equity (ROE)	0.00%	-8.90%	-4.95%	-1.89%
Cash Return on Invested Capital (CROIC)	0.00%	-199.11%	5.49%	3.96%
Operating Return on Assets (OROA)	0.00%	1.20%	1.73%	1.97%
Return on Assets (ROA)	0.00%	-3.07%	-1.64%	-0.79%
Return on Common Equity (ROCE)	0.00%	-7.55%	-4.25%	-1.78%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-5.24%	-6.05%	-1.57%
Net Operating Profit after Tax (NOPAT)	14	20	33	59
NOPAT Margin	1.12%	1.19%	1.77%	2.84%
Net Nonoperating Expense Percent (NNEP)	0.00%	6.83%	4.05%	4.22%
Return On Investment Capital (ROIC_SIMPLE)	-	0.45%	0.79%	1.42%
Cost of Revenue to Revenue	80.34%	77.99%	80.48%	79.87%
SG&A Expenses to Revenue	3.37%	2.64%	2.55%	2.30%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	18.05%	20.31%	16.99%	16.08%
Earnings before Interest and Taxes (EBIT)	28	29	81	89
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	186	229	318	311
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	1.92
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	2.33
Price to Revenue (P/Rev)	0.00	0.00	0.00	2.10
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	3.52%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	1.51
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	2.97
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	19.78
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	68.85
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	104.77
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	34.94
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	37.74
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	1.69	1.89	0.80
Long-Term Debt to Equity	0.00	1.69	1.89	0.80
Financial Leverage	0.00	1.65	1.75	1.19
Leverage Ratio	0.00	2.90	3.01	2.41
Compound Leverage Factor	0.00	-7.36	-2.83	-0.91
Debt to Total Capital	0.00%	62.80%	65.35%	44.34%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	62.80%	65.35%	44.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	5.62%	4.48%	1.04%
Common Equity to Total Capital	0.00%	31.58%	30.17%	54.62%
Debt to EBITDA	0.00	12.15	8.64	5.90
Net Debt to EBITDA	0.00	11.86	8.51	5.66
Long-Term Debt to EBITDA	0.00	12.15	8.64	5.90
Debt to NOPAT	0.00	142.52	83.23	31.26
Net Debt to NOPAT	0.00	139.19	81.92	29.96
Long-Term Debt to NOPAT	0.00	142.52	83.23	31.26
Altman Z-Score	0.00	0.00	0.00	1.28
Noncontrolling Interest Sharing Ratio	0.00%	15.11%	14.09%	6.16%
Liquidity Ratios	-	-	-	-
Current Ratio	0.00	0.83	0.94	1.11
Quick Ratio	0.00	0.83	0.94	1.11
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-4,349	234	163
Operating Cash Flow to CapEx	23.82%	153.20%	0.00%	1,597.89%
Free Cash Flow to Firm to Interest Expense	0.00	-41.05	1.44	1.28
Operating Cash Flow to Interest Expense	0.22	1.39	0.60	1.38
Operating Cash Flow Less CapEx to Interest Expense	-0.71	0.48	0.85	1.29
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.69	0.40	0.46
Accounts Receivable Turnover	0.00	0.00	11.56	10.45
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.53	0.61
Accounts Payable Turnover	0.00	0.00	6.17	6.60
Days Sales Outstanding (DSO)	0.00	0.00	31.57	34.94
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	59.13	55.31
Cash Conversion Cycle (CCC)	0.00	0.00	-27.56	-20.36
Capital & Investment Metrics	-	-	-	-
Invested Capital	0.00	4,369	4,168	4,063
Invested Capital Turnover	0.00	0.75	0.44	0.50
Increase / (Decrease) in Invested Capital	0.00	4,369	-201	-104
Enterprise Value (EV)	0.00	0.00	0.00	6,152
Market Capitalization	0.00	0.00	0.00	4,350
Book Value per Share	$0.00	$21.28	$19.18	$14.77
Tangible Book Value per Share	$0.00	$14.17	$12.91	$12.18
Total Capital	0.00	4,434	4,211	4,140
Total Debt	0.00	2,785	2,752	1,836
Total Long-Term Debt	0.00	2,785	2,752	1,836
Net Debt	0.00	2,720	2,708	1,759
Capital Expenditures (CapEx)	75	96	-39	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-106	-58	-47
Debt-free Net Working Capital (DFNWC)	0.00	-41	-14	29
Net Working Capital (NWC)	0.00	-41	-14	29
Net Nonoperating Expense (NNE)	68	93	110	94
Net Nonoperating Obligations (NNO)	0.00	2,720	2,708	1,759
Total Depreciation and Amortization (D&A)	157	201	237	222
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-6.47%	-3.08%	-2.28%
Debt-free Net Working Capital to Revenue	0.00%	-2.51%	-0.75%	1.42%
Net Working Capital to Revenue	0.00%	-2.51%	-0.75%	1.42%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($1.08)	($0.29)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	66.05M	130.64M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($1.08)	($0.29)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	66.05M	130.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	65.37M	157.57M
Normalized Net Operating Profit after Tax (NOPAT)	26	63	54	96
Normalized NOPAT Margin	2.02%	3.86%	2.88%	4.62%
Pre Tax Income Margin	-4.08%	-4.43%	-4.08%	-1.64%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.35	0.27	0.50	0.70
NOPAT to Interest Expense	0.18	0.18	0.20	0.46
EBIT Less CapEx to Interest Expense	-0.58	-0.64	0.74	0.61
NOPAT Less CapEx to Interest Expense	-0.75	-0.73	0.44	0.37
Payout Ratios	-	-	-	-
Dividend Payout Ratio	-73.49%	-91.29%	-112.36%	-349.76%
Augmented Payout Ratio	-74.22%	-122.34%	-114.90%	-554.07%

This table displays calculated financial ratios and metrics derived from American Healthcare REIT's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	8.94%	0.00%	10.46%	7.92%	12.83%	12.47%
EBITDA Growth	0.00%	0.00%	0.00%	0.00%	62.72%	8.43%	16.40%	5.09%	-16.71%	-12.48%
EBIT Growth	0.00%	0.00%	0.00%	0.00%	75.78%	0.00%	222.89%	19.05%	-20.36%	-136.54%
NOPAT Growth	0.00%	0.00%	0.00%	0.00%	-95.70%	0.00%	159.52%	59.30%	3,601.53%	-146.62%
Net Income Growth	0.00%	0.00%	0.00%	0.00%	15.67%	0.00%	89.12%	124.66%	52.02%	-4.75%
EPS Growth	0.00%	0.00%	0.00%	0.00%	57.14%	0.00%	89.74%	105.26%	66.67%	43.90%
Operating Cash Flow Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-24.93%	-124.95%	200.31%	116.76%	130.93%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	94.45%	-52.71%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-4.61%	0.00%	0.00%	6.14%	-2.50%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	3.39%	-0.71%	3.95%	3.51%	1.01%	3.81%	3.61%
EBITDA Q/Q Growth	0.00%	-5.88%	33.07%	11.55%	16.46%	-37.28%	42.85%	0.72%	-7.70%	-34.10%
EBIT Q/Q Growth	0.00%	-100.00%	0.00%	163.70%	28.15%	-73.23%	256.99%	-2.77%	-14.27%	-112.28%
NOPAT Q/Q Growth	0.00%	-100.00%	0.00%	140.75%	-96.03%	1,404.92%	80.30%	47.78%	-7.69%	-118.95%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	57.03%	45.68%	-380.28%	90.30%	197.40%	-205.71%	-948.46%
EPS Q/Q Growth	0.00%	0.00%	0.00%	51.28%	52.63%	-355.56%	90.24%	125.00%	-400.00%	-666.67%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-30.49%	-17.11%	47.24%	-11.52%	-123.11%	1,097.68%	6.28%	-5.74%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	105.28%	-2,116.48%	0.90%	94.74%	144.98%
Invested Capital Q/Q Growth	0.00%	0.00%	-100.00%	0.00%	0.00%	4.27%	2.54%	-0.71%	-0.02%	-4.22%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	20.81%	0.00%	18.15%	20.32%	19.31%	20.22%	19.20%	20.22%	20.37%	20.67%
EBITDA Margin	14.10%	0.00%	16.65%	17.96%	21.07%	12.71%	17.54%	17.49%	15.55%	9.89%
Operating Margin	4.99%	0.00%	2.11%	4.92%	0.20%	2.85%	4.96%	6.28%	6.46%	-1.18%
EBIT Margin	4.62%	0.00%	2.26%	5.77%	7.45%	1.92%	6.62%	6.37%	5.26%	-0.62%
Profit (Net Income) Margin	-1.79%	0.00%	-6.11%	-2.54%	-1.39%	-6.42%	-0.60%	0.58%	-0.59%	-5.98%
Tax Burden Percent	101.68%	0.00%	100.52%	103.02%	104.61%	99.64%	110.20%	81.01%	109.29%	101.52%
Interest Burden Percent	-38.20%	0.00%	-268.36%	-42.67%	-17.81%	-335.58%	-8.25%	11.24%	-10.27%	944.22%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	18.99%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.87%	3.11%	4.68%	2.21%	-0.42%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	-0.62%	1.20%	2.55%	1.00%	-1.67%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	-1.09%	1.19%	2.59%	1.18%	-1.98%
Return on Equity (ROE)	0.00%	0.00%	0.00%	0.00%	0.00%	-0.22%	4.31%	7.27%	3.38%	-2.39%
Cash Return on Invested Capital (CROIC)	0.00%	-99.55%	0.00%	0.00%	0.00%	5.49%	-197.95%	-197.65%	-4.19%	3.96%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.76%	5.39%	5.35%	2.28%	-0.28%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	0.00%	-2.56%	-0.49%	0.49%	-0.26%	-2.73%
Return on Common Equity (ROCE)	0.00%	0.00%	0.00%	0.00%	0.00%	-0.18%	3.94%	6.68%	3.14%	-2.25%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-2.67%	-1.94%	-1.55%	0.00%
Net Operating Profit after Tax (NOPAT)	15	0.00	6.69	16	0.64	9.63	17	26	24	-4.49
NOPAT Margin	3.49%	0.00%	1.48%	3.44%	0.14%	2.00%	3.48%	5.08%	4.52%	-0.83%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	0.00%	0.00%	0.58%	1.50%	1.91%	2.13%	1.20%	1.25%
Return On Investment Capital (ROIC_SIMPLE)	-	0.00%	-	-	-	0.23%	-	-	-	-0.11%
Cost of Revenue to Revenue	79.19%	0.00%	81.85%	79.68%	80.69%	79.78%	80.80%	79.78%	79.63%	79.33%
SG&A Expenses to Revenue	2.26%	0.00%	2.89%	2.52%	2.44%	2.35%	2.37%	2.33%	2.28%	2.22%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	15.82%	0.00%	16.04%	15.40%	19.11%	17.37%	14.23%	13.94%	13.91%	21.85%
Earnings before Interest and Taxes (EBIT)	20	0.00	10	27	35	9.26	33	32	28	-3.38
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	60	57	75	84	98	61	88	88	81	54
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.48	0.99	1.56	1.92
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.62	1.27	1.91	2.33
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.99	1.71	2.10
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.72%	3.42%	2.87%	3.52%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.76	1.00	1.29	1.51
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	1.70	2.17	2.72	2.97
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	9.86	12.64	17.17	19.78
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	31.38	38.82	53.64	68.85
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	74.55	85.01	75.11	104.77
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	47.45	39.07	38.43	34.94
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	37.74
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	1.69	0.00	0.00	1.63	1.89	1.03	1.04	0.91	0.80
Long-Term Debt to Equity	0.00	1.69	0.00	0.00	1.63	1.89	1.03	1.04	0.91	0.80
Financial Leverage	0.00	1.65	0.00	0.00	1.61	1.75	0.99	1.02	1.17	1.19
Leverage Ratio	0.00	2.90	0.00	0.00	2.99	3.01	2.20	2.21	2.44	2.41
Compound Leverage Factor	0.00	0.00	0.00	0.00	-0.53	-10.11	-0.18	0.25	-0.25	22.75
Debt to Total Capital	0.00%	62.80%	0.00%	0.00%	61.96%	65.35%	50.74%	51.01%	47.63%	44.34%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	62.80%	0.00%	0.00%	61.96%	65.35%	50.74%	51.01%	47.63%	44.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	5.62%	0.00%	0.00%	5.44%	4.48%	4.18%	3.98%	1.15%	1.04%
Common Equity to Total Capital	0.00%	31.58%	0.00%	0.00%	32.60%	30.17%	45.07%	45.01%	51.22%	54.62%
Debt to EBITDA	0.00	12.15	0.00	0.00	10.33	8.64	6.67	6.54	6.44	5.90
Net Debt to EBITDA	0.00	11.86	0.00	0.00	10.19	8.51	6.44	6.39	6.23	5.66
Long-Term Debt to EBITDA	0.00	12.15	0.00	0.00	10.33	8.64	6.67	6.54	6.44	5.90
Debt to NOPAT	0.00	142.52	0.00	0.00	0.00	83.23	50.48	44.00	28.19	31.26
Net Debt to NOPAT	0.00	139.19	0.00	0.00	0.00	81.92	48.72	42.95	27.25	29.96
Long-Term Debt to NOPAT	0.00	142.52	0.00	0.00	0.00	83.23	50.48	44.00	28.19	31.26
Altman Z-Score	0.00	0.00	0.00	0.00	0.00	0.00	0.27	0.49	0.89	1.21
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	14.31%	14.09%	8.49%	8.11%	7.10%	6.16%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	0.83	0.00	0.00	0.87	0.94	1.14	1.00	1.01	1.11
Quick Ratio	0.00	0.83	0.00	0.00	0.87	0.94	1.14	1.00	1.01	1.11
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	0.00	0.00	-3,996	211	-4,256	-4,217	-222	100
Operating Cash Flow to CapEx	0.00%	0.00%	90.80%	0.00%	0.00%	295.04%	-104.16%	92.00%	213.63%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	-95.14	5.12	-116.80	-137.84	-7.30	3.29
Operating Cash Flow to Interest Expense	0.00	0.00	0.61	0.48	0.69	0.63	-0.16	1.94	2.08	1.96
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-0.06	1.69	1.29	0.41	-0.32	-0.17	1.10	4.90
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.69	0.00	0.00	0.00	0.40	0.81	0.84	0.43	0.46
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	11.56	0.00	0.00	10.78	10.45
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.53	0.00	0.00	0.00	0.61
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	6.17	0.00	0.00	6.39	6.60
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	31.57	0.00	0.00	33.87	34.94
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	59.13	0.00	0.00	57.16	55.31
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	-27.56	0.00	0.00	-23.28	-20.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	4,369	0.00	0.00	3,997	4,168	4,273	4,243	4,242	4,063
Invested Capital Turnover	0.00	0.38	0.00	0.00	0.00	0.44	0.90	0.92	0.49	0.50
Increase / (Decrease) in Invested Capital	0.00	0.00	0.00	0.00	3,997	-201	4,273	4,243	246	-104
Enterprise Value (EV)	0.00	0.00	0.00	0.00	0.00	0.00	3,260	4,233	5,471	6,152
Market Capitalization	0.00	0.00	0.00	0.00	0.00	0.00	948	1,923	3,436	4,350
Book Value per Share	$0.00	$21.28	$0.00	$0.00	$19.90	$19.18	$30.00	$14.69	$16.77	$14.77
Tangible Book Value per Share	$0.00	$14.17	$0.00	$0.00	$13.36	$12.91	$23.53	$11.54	$13.63	$12.18
Total Capital	0.00	4,434	0.00	0.00	4,032	4,211	4,350	4,295	4,310	4,140
Total Debt	0.00	2,785	0.00	0.00	2,498	2,752	2,208	2,191	2,053	1,836
Total Long-Term Debt	0.00	2,785	0.00	0.00	2,498	2,752	2,208	2,191	2,053	1,836
Net Debt	0.00	2,720	0.00	0.00	2,463	2,708	2,130	2,139	1,985	1,759
Capital Expenditures (CapEx)	0.00	-4.41	26	-49	-25	8.73	5.72	65	30	-89
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-106	0.00	0.00	-64	-58	-41	-53	-66	-47
Debt-free Net Working Capital (DFNWC)	0.00	-41	0.00	0.00	-29	-14	36	-0.54	1.74	29
Net Working Capital (NWC)	0.00	-41	0.00	0.00	-29	-14	36	-0.54	1.74	29
Net Nonoperating Expense (NNE)	23	0.00	34	28	7.09	41	20	23	27	28
Net Nonoperating Obligations (NNO)	0.00	2,720	0.00	0.00	2,463	2,708	2,130	2,139	1,985	1,759
Total Depreciation and Amortization (D&A)	40	57	65	57	63	52	55	56	54	57
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-6.47%	0.00%	0.00%	0.00%	-3.08%	-2.16%	-2.70%	-3.29%	-2.28%
Debt-free Net Working Capital to Revenue	0.00%	-2.51%	0.00%	0.00%	0.00%	-0.75%	1.86%	-0.03%	0.09%	1.42%
Net Working Capital to Revenue	0.00%	-2.51%	0.00%	0.00%	0.00%	-0.75%	1.86%	-0.03%	0.09%	1.42%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	($0.09)	($0.41)	($0.04)	$0.01	($0.03)	($0.23)
Adjusted Weighted Average Basic Shares Outstanding	0.00	65.81M	0.00	0.00	66.05M	66.05M	104.30M	130.53M	133.73M	130.64M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($0.09)	($0.41)	($0.04)	$0.01	($0.03)	($0.23)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	65.81M	0.00	0.00	66.05M	66.05M	104.30M	130.69M	133.73M	130.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	0.00	66.23M	65.37M	131.65M	131.65M	153.06M	157.57M
Normalized Net Operating Profit after Tax (NOPAT)	17	0.00	6.41	17	10	12	19	26	26	-3.92
Normalized NOPAT Margin	3.91%	0.00%	1.42%	3.58%	2.18%	2.51%	3.87%	5.09%	4.99%	-0.72%
Pre Tax Income Margin	-1.76%	0.00%	-6.07%	-2.46%	-1.33%	-6.44%	-0.55%	0.72%	-0.54%	-5.89%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.72	0.00	0.26	0.66	0.82	0.22	0.91	1.05	0.91	-0.11
NOPAT to Interest Expense	0.54	0.00	0.17	0.39	0.02	0.23	0.48	0.84	0.78	-0.15
EBIT Less CapEx to Interest Expense	0.72	0.00	-0.41	1.86	1.42	0.01	0.75	-1.06	-0.07	2.82
NOPAT Less CapEx to Interest Expense	0.54	0.00	-0.50	1.60	0.61	0.02	0.32	-1.27	-0.19	2.78
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	-91.29%	0.00%	0.00%	0.00%	-112.36%	-140.42%	-232.75%	-303.75%	-349.76%
Augmented Payout Ratio	0.00%	-122.34%	0.00%	0.00%	0.00%	-114.90%	-234.96%	-367.46%	-570.25%	-554.07%

Frequently Asked Questions About American Healthcare REIT's Financials

When does American Healthcare REIT's fiscal year end?

According to the most recent income statement we have on file, American Healthcare REIT's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has American Healthcare REIT's net income changed over the last 3 years?

American Healthcare REIT's net income appears to be on a downward trend, with a most recent value of -$35.60 million in 2024, falling from -$53.27 million in 2021. The previous period was -$76.89 million in 2023. View American Healthcare REIT's forecast to see where analysts expect American Healthcare REIT to go next.

What is American Healthcare REIT's operating income?

American Healthcare REIT's total operating income in 2024 was $83.89 million, based on the following breakdown:

Total Gross Profit: $416.78 million
Total Operating Expenses: $332.89 million

How has American Healthcare REIT revenue changed over the last 3 years?

Over the last 3 years, American Healthcare REIT's total revenue changed from $1.28 billion in 2021 to $2.07 billion in 2024, a change of 61.5%.

How much debt does American Healthcare REIT have?

American Healthcare REIT's total liabilities were at $2.18 billion at the end of 2024, a 30.0% decrease from 2023, and a 30.4% decrease since 2022.

How much cash does American Healthcare REIT have?

In the past 2 years, American Healthcare REIT's cash and equivalents has ranged from $43.45 million in 2023 to $76.70 million in 2024, and is currently $76.70 million as of their latest financial filing in 2024.

How has American Healthcare REIT's book value per share changed over the last 3 years?

Over the last 3 years, American Healthcare REIT's book value per share changed from 0.00 in 2021 to 14.77 in 2024, a change of 1,477.3%.

Related Companies

This page (NYSE:AHR) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

American Healthcare REIT (AHR) Financials

Frequently Asked Questions About American Healthcare REIT's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

American Healthcare REIT (AHR) Financials

Annual Income Statements for American Healthcare REIT

Quarterly Income Statements for American Healthcare REIT

Annual Cash Flow Statements for American Healthcare REIT

Quarterly Cash Flow Statements for American Healthcare REIT

Annual Balance Sheets for American Healthcare REIT

Quarterly Balance Sheets for American Healthcare REIT

Annual Metrics and Ratios for American Healthcare REIT

Quarterly Metrics and Ratios for American Healthcare REIT

Frequently Asked Questions About American Healthcare REIT's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools